Summarizes clinical trial evidence suggesting a possible link between angiotensin receptor blocker use and cancer, additional clinical evidence tending to refute a link, basic science evidence, and recent information about the problem of potentially cancer-causing impurities found in some angiotensin receptor blocker products.
Our analysis of data from FDA's assessment of currently marketed angiotensin receptor blocker drugs, with regard to nitrosamine impurities
We review the recent guidelines addressing the diagnosis and management of hypertension.
Proposes a framework for thinking about pragmatic, one-size-fits-most treatment and highly personalized treatment of hypertension.
This study aims to evaluate the 4 non- pharmacological strategies adopted by patients for hypertension control and patient characteristics that affect the choice of strategies. Four thousand hypertensive patients aged ???18 years were selected from …
**BACKGROUND:** Prior unblinded studies have suggested that catheter-based renal-artery denervation reduces blood pressure in patients with resistant hypertension. **METHODS:** We designed a prospective, single-blind, randomized, sham-controlled …